| Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival—The University of Texas … M Blum Murphy, L Xiao, VR Patel, DM Maru, AM Correa, F G. Amlashi, ... Cancer 123 (21), 4106-4113, 2017 | 147 | 2017 |
| Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury SY Chabok, AD Moghadam, Z Saneei, FG Amlashi, EK Leili, ZM Amiri Journal of Trauma and Acute Care Surgery 72 (6), 1654-1657, 2012 | 137 | 2012 |
| Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response R Wang, S Song, K Harada, FG Amlashi, B Badgwell, MP Pizzi, Y Xu, ... Gut 69 (1), 18-31, 2020 | 127 | 2020 |
| Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management FG Amlashi, NA Tritos Endocrine 52, 427-440, 2016 | 99 | 2016 |
| Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease. FG Amlashi, B Swearingen, AT Faje, LB Nachtigall, KK Miller, A Klibanski, ... The journal of clinical endocrinology and metabolism 100 (10), 3770-7, 2015 | 62 | 2015 |
| Bone microarchitecture and estimated bone strength in men with active acromegaly PPB Silva, FG Amlashi, EW Yu, KJ Pulaski-Liebert, AV Gerweck, ... European Journal of Endocrinology 177 (5), 409-420, 2017 | 37 | 2017 |
| Advanced gastric adenocarcinoma: optimizing therapy options. D Mizrak Kaya, K Harada, Y Shimodaira, A Fatemeh G, Q Lin, JA Ajani Expert Review of clinical Pharmacology, 2017 | 30 | 2017 |
| Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma D Mizrak Kaya, GM Nogueras‐González, K Harada, FG Amlashi, ... Journal of surgical oncology 117 (4), 678-684, 2018 | 18 | 2018 |
| Ovarian cyst regression with levothyroxine in ovarian hyperstimulation syndrome associated with hypothyroidism RM Langroudi, FG Amlashi, MHH Emami Endocrinology, diabetes & metabolism case reports 2013 (1), 2013 | 17 | 2013 |
| 101 long-term survivors who had metastatic gastroesophageal cancer and received local consolidative therapy D Mizrak Kaya, X Wang, K Harada, MA Blum Murphy, P Das, BD Minsky, ... Oncology 93 (4), 243-248, 2017 | 15 | 2017 |
| Total lesion glycolysis assessment identifies a patient fraction with a high cure rate among esophageal adenocarcinoma patients treated with definitive chemoradiation K Harada, CC Wu, X Wang, DM Kaya, FG Amlashi, M Iwatsuki, ... Annals of surgery 272 (2), 311-318, 2020 | 13 | 2020 |
| Early metabolic change after induction chemotherapy predicts histologic response and prognosis in patients with esophageal cancer: secondary analysis of a randomized trial K Harada, X Wang, Y Shimodaira, T Sagebiel, MS Bhutani, JH Lee, ... Targeted oncology 13, 99-106, 2018 | 13 | 2018 |
| Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial Y Shimodaira, RS Slack, K Harada, HC Chen, T Sagebiel, MS Bhutani, ... British journal of cancer 118 (3), 331-337, 2018 | 12 | 2018 |
| Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma AJA Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K ... Annal Surgical Oncology, 2016 | 11* | 2016 |
| Potentially curable gastric adenocarcinoma treated without surgery DM Kaya, GM Nogueras-Gonzáles, K Harada, FG Amlashi, I Thomas, ... European Journal of Cancer 98, 23-29, 2018 | 10 | 2018 |
| The role of chemotherapy in unresectable or metastatic adenocarcinoma of the stomach and gastroesophageal junction. M Bozkurt, FG Amlashi Minerva chirurgica 72 (4), 317-333, 2017 | 8 | 2017 |
| Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients D Mizrak Kaya, X Dong, GM Nogueras-González, Y Xu, JS Estrella, ... Medical Oncology 34, 1-7, 2017 | 6 | 2017 |
| Ovarian hyperstimulation syndrome and autoimmune primary hypothyroidism in two members of a family MH Hedayati Emami, R Molaei Langroudi, F Ghazanfari Amlashi Journal of Clinical Case Reports 2 (113), 10.4172, 2012 | 6 | 2012 |
| Ramucirumab and paclitaxel administered every 2 weeks (mRAINBOW Regimen) in advanced gastroesophageal adenocarcinoma JE Rogers, L Xiao, FG Amlashi, E Elimova, MA Blum Murphy, E Sanders, ... Oncology 96 (5), 252-258, 2019 | 5 | 2019 |
| Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients A Lopez, K Harada, HC Chen, MS Bhutani, B Weston, JH Lee, DM Maru, ... Medicine 99 (9), e19295, 2020 | 4 | 2020 |
